Home/MitoRx Therapeutics/Glyn Edwards

GE

Glyn Edwards

Chairman of the Board

MitoRx Therapeutics

Therapeutic Areas

Obesity Cardiometabolic Disease

MitoRx Therapeutics Pipeline

Drug	Indication	Phase
Intermittent Injectable Program	Obesity	Preclinical
Oral Program	Obesity	Preclinical

Leadership Team at MitoRx Therapeutics

CEO and Co-founder

Chief Business Officer

Prof. Matt Whiteman

Chief Scientific Officer (CSO) and Co-founder

Dr. David Holbrook

Independent Non-Executive Director

View full MitoRx Therapeutics profile